Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Operating Margin (2021)

Atea Pharmaceuticals has reported Operating Margin over the past 1 years, most recently at 63.06% for Q4 2021.

  • Quarterly results put Operating Margin at 63.06% for Q4 2021, changed N/A from a year ago — trailing twelve months through Sep 2022 was 15.83% (down 794.0% YoY), and the annual figure for FY2021 was 39.38%, up 6206.0%.
  • Operating Margin for Q4 2021 was 63.06% at Atea Pharmaceuticals, up from 67.5% in the prior quarter.
  • Over the last five years, Operating Margin for AVIR hit a ceiling of 63.06% in Q4 2021 and a floor of 67.5% in Q3 2021.